Interaction of adenosine 3',5'-monophosphate derivatives with the gonadotropin-releasing hormone receptor on pituitary and ovary.
D015762:2-Chloroadenosine; D015124:8-Bromo Cyclic Adenosine Monophosphate; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002417:Cattle; D000242:Cyclic AMP / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D008297:Male; D010053:Ovary / Q000378:metabolism*; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011966:Receptors, LHRH; D013873:Thionucleotides / Q000494:pharmacology
D011956:Receptors, Cell Surface; D011966:Receptors, LHRH; D013873:Thionucleotides; D015762:2-Chloroadenosine; D015124:8-Bromo Cyclic Adenosine Monophosphate; D000249:Adenosine Monophosphate; C015929:8-((4-chlorophenyl)thio)cyclic-3',5'-AMP; D003994:Bucladesine; D000242:Cyclic AMP; D000241:Adenosine